Company intelligence / Profile preview

EverHope Capital

Shanghai, China

Ownership: Private
Development stage: Other

Overview

EverHope Capital is a healthcare-focused venture capital firm that invests in innovative life science companies globally. Founded by Dr. Yi Shi, the former founding managing partner of Lilly Asia Ventures (LAV), the firm leverages deep industry expertise to support startups in therapeutics, medical devices, and diagnostics. EverHope Capital primarily targets early-to-growth stage opportunities, with a strategic focus on the China and United States markets. The firm aims to accelerate the translation of scientific breakthroughs into clinical solutions for patients worldwide by bridging the gap between global innovation and market access.

Industry: Investors

Beyond the preview

Go deeper on EverHope Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EverHope Capital.

Explore the full profile